Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schoppet

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 15, 2013
Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO studyPawel Szulc, Stéphanie Boutroy, Nicolas Vilayphiou, et al.
Journal of Cellular Biochemistry|June 23, 2009
Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosisTilman D Rachner, Peggy Benad, Martina Rauner, et al.
Cardiovascular Research|March 31, 2011
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcificationBelinda A Di Bartolo, Michael Schoppet, Muhammad Z Mattar, et al.
Plos One|September 17, 2013
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKLBelinda A Di Bartolo, Siân P Cartland, Hanis H Harith, et al.
Clinical Biochemistry|December 29, 2011
Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusionsKonstantinos Karatolios, Sabine Pankuweit, Claudia Goettsch, et al.
Thrombosis and Haemostasis|April 8, 2006
Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cellsLorenz C Hofbauer, Jörg Schrader, Ute Niebergall, et al.
Biochemical and Biophysical Research Communications|November 18, 2005
TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathyMichael Schoppet, Volker Ruppert, Lorenz C Hofbauer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 7, 2008
Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathwayNicola C Stein, Carmen Kreutzmann, Sara-Pia Zimmermann, et al.
Arthritis and Rheumatism|May 1, 2009
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKLLorenz C Hofbauer, Ute Zeitz, Michael Schoppet, et al.
Thrombosis and Haemostasis|October 25, 2012
Calcification inhibitors in vascular calciphylaxis associated with normal renal functionVincent Brandenburg, Nadia Al-Fakhri, Katharina Nemeth, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 15, 2013
Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO studyPawel Szulc, Stéphanie Boutroy, Nicolas Vilayphiou, et al.
Journal of Cellular Biochemistry|June 23, 2009
Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosisTilman D Rachner, Peggy Benad, Martina Rauner, et al.
Cardiovascular Research|March 31, 2011
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcificationBelinda A Di Bartolo, Michael Schoppet, Muhammad Z Mattar, et al.
Plos One|September 17, 2013
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKLBelinda A Di Bartolo, Siân P Cartland, Hanis H Harith, et al.
Clinical Biochemistry|December 29, 2011
Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusionsKonstantinos Karatolios, Sabine Pankuweit, Claudia Goettsch, et al.
Thrombosis and Haemostasis|April 8, 2006
Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cellsLorenz C Hofbauer, Jörg Schrader, Ute Niebergall, et al.
Biochemical and Biophysical Research Communications|November 18, 2005
TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathyMichael Schoppet, Volker Ruppert, Lorenz C Hofbauer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 7, 2008
Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathwayNicola C Stein, Carmen Kreutzmann, Sara-Pia Zimmermann, et al.
Arthritis and Rheumatism|May 1, 2009
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKLLorenz C Hofbauer, Ute Zeitz, Michael Schoppet, et al.
Thrombosis and Haemostasis|October 25, 2012
Calcification inhibitors in vascular calciphylaxis associated with normal renal functionVincent Brandenburg, Nadia Al-Fakhri, Katharina Nemeth, et al.
Pageof 5